Interestingly, in a dataset comparing gene expression of CAF from breast cancer patients resistant vs sensitive to neoadjuvant chemotherapy, EFEMP1 was found significantly downmodulated in the resistant group. Here, EFEMP1 is linked to breast carcinoma.